Sjoberg E R, Kitagawa H, Glushka J, van Halbeek H, Paulson J C
Cytel Corporation, San Diego, California, 92121, USA.
J Biol Chem. 1996 Mar 29;271(13):7450-9. doi: 10.1074/jbc.271.13.7450.
A cDNA encoding a novel sialyltransferase has been isolated employing the polymerase chain reaction using degenerate primers to conserved regions of the sialylmotif that is present in all eukaryotic members of the sialyltransferase gene family examined to date. The cDNA sequence revealed an open reading frame coding for 305 amino acids, making it the shortest sialyltransferase cloned to date. This open reading frame predicts all the characteristic structural features of other sialyltransferases including a type II membrane protein topology and both sialylmotifs, one centrally located and the second in the carboxyl-terminal portion of the cDNA. When compared with all other sialyltransferase cDNAs, the predicted amino acid sequence displays the lowest homology in the sialyltransferase gene family. Northern analysis shows this sialyltransferase to be developmentally regulated in brain with expression persisting through adulthood in spleen, kidney, and lung. Stable transfection of the full-length cDNA in the human kidney carcinoma cell line 293 produced an active sialyltransferase with marked specificity for the sialoside, Neu5Ac-alpha2,3Gal-beta1,3GalNAc and glycoconjugates carrying the same sequence such as G(M1b) and fetuin. The disialylated tetrasaccharide formed by reacting the sialyltransferase with the aforementioned sialoside was analyzed by one- and two-dimensional 1H and 13C NMR spectroscopy and was shown to be the Neu5Ac-alpha2,3Gal-beta1,3(Neu5Ac-alpha2,6)GalNAc sialoside. This indicates that the enzyme is a GalNAc alpha-2,6-sialyltransferase. Since two other ST6GalNAc sialyltransferase cDNAs have been isolated, this sialyltransferase has been designated ST6GalNAc III. Of these three, ST6GalNAc III displays the most restricted acceptor specificity and is the only sialyltransferase cloned to date capable of forming the developmentally regulated ganglioside G(D1alpha) from G(M1b).
利用聚合酶链反应,使用简并引物针对唾液酸基序的保守区域进行扩增,分离出了一个编码新型唾液酸转移酶的cDNA。该唾液酸基序存在于迄今为止所研究的唾液酸转移酶基因家族的所有真核成员中。cDNA序列揭示了一个编码305个氨基酸的开放阅读框,使其成为迄今克隆的最短的唾液酸转移酶。这个开放阅读框预测了其他唾液酸转移酶的所有特征性结构特征,包括II型膜蛋白拓扑结构和两个唾液酸基序,一个位于中央,另一个位于cDNA的羧基末端部分。与所有其他唾液酸转移酶cDNA相比,预测的氨基酸序列在唾液酸转移酶基因家族中显示出最低的同源性。Northern分析表明,这种唾液酸转移酶在大脑中受发育调控,在脾脏、肾脏和肺中表达持续至成年期。将全长cDNA稳定转染至人肾癌细胞系293中,产生了一种活性唾液酸转移酶,该酶对唾液酸苷Neu5Ac-α2,3Gal-β1,3GalNAc以及携带相同序列的糖缀合物(如G(M1b)和胎球蛋白)具有显著的特异性。通过一维和二维1H和13C NMR光谱分析了唾液酸转移酶与上述唾液酸苷反应形成的二唾液酸化四糖,结果表明其为Neu5Ac-α2,3Gal-β1,3(Neu5Ac-α2,6)GalNAc唾液酸苷。这表明该酶是一种GalNAc α-2,6-唾液酸转移酶。由于已经分离出另外两个ST6GalNAc唾液酸转移酶cDNA,因此该唾液酸转移酶被命名为ST6GalNAc III。在这三种酶中,ST6GalNAc III表现出最受限的受体特异性,并且是迄今克隆的唯一能够从G(M1b)形成受发育调控的神经节苷脂G(D1α)的唾液酸转移酶。